Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy Nov 29, 2023 Eugene Braunwald , Sara Saberi, Theodore P. Abraham, Perry M. Elliott, and Iacopo Olivotto
